Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Chengwei Capital

Founders Eric X Li

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 97
Average round size
info
The average size of a deal this fund participated in
$31M
Portfolio companies 68
Rounds per year 3.88
Lead investments 23
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.29
Exits 6
Key employees 5
Stages of investment
Early Stage Venture
Late Stage Venture

Areas of investment

  • Internet
  • Software
  • Information Technology
  • E-Commerce
  • Health Care
Summary

Chengwei Capital appeared to be the VC, which was created in 1999. The venture was found in Asia in China. The main department of described VC is located in the Shanghai.

The typical case for the fund is to invest in rounds with 3-4 participants. Despite the Chengwei Capital, startups are often financed by Sutter Hill Ventures, Source Code Capital, Farallon Capital Management. The meaningful sponsors for the fund in investment in the same round are Source Code Capital, Sinovation Ventures, Yunqi Partners. In the next rounds fund is usually obtained by Sutter Hill Ventures, Source Code Capital, Ant Financial.

We can highlight the next thriving fund investment areas, such as Internet, Service Industry. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. Among the various public portfolio startups of the fund, we may underline Youku, Hellobike, Apus Group The fund has exact preference in a number of founders of portfolio startups. In case when startup counts 4 of the founder, the chance for it to get the investment is meager. For fund there is a match between the location of its establishment and the land of its numerous investments - China.

The fund was created by Eric X Li. Besides them, we counted 5 critical employees of this fund in our database.

Speaking about the real fund results, this VC is 19 percentage points more often commits exit comparing to other organizations. Comparing to the other companies, this Chengwei Capital performs on 20 percentage points less the average number of lead investments. The typical startup value when the investment from Chengwei Capital is 500 millions - 1 billion dollars. The usual things for fund are deals in the range of 10 - 50 millions dollars. The important activity for fund was in 2018. The increased amount of exits for fund were in 2019. The fund is generally included in 2-6 deals every year.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Chengwei Capital:
Typical Co-investors
Chengwei Capital is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Chengwei Capital:

Funds with similar focus

Funds from China
Funds with similar focus located in China:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Biohem

$15M06 Mar 2024 Shanghai, Shanghai, China

Full-Life Technologies

Health Care
Manufacturing
Pharmaceutical
$47M03 Jan 2024 Shanghai, Shanghai, China

Perpetual Medicines

Biotechnology
$8M30 Nov 2023 -

Jushu Biotech

Biopharma
Biotechnology
Genetics
Medical
$15M17 Nov 2023 Changping, Beijing, China

Daochong Technology

Industrial Manufacturing
Information Technology
Wireless
07 Nov 2023 Yinzhou, Zhejiang, China

Huizhi International Tourism

Digital Marketing
Travel
Travel Agency
25 Sep 2023 Guangzhou, Guangdong, China

AroundDeal

Business Intelligence
Database
Information Technology
Lead Generation
Marketing
SaaS
Software
21 Jun 2023 Shanghai, Shanghai, China

Xunyuan Technology

Biopharma
Health Care
Medical
08 Feb 2023 Chongqing, Chongqing Shi, China

Jushu Biotech

Biopharma
Biotechnology
Genetics
Medical
$1M13 Jan 2023 Changping, Beijing, China
News
Rapid Silicon Announces Seed Funding of $15M

– Rapid Silicon, a provider of AI-enabled application-specific FPGAs based on open-source technology, announced $15 million in seed funding led by ChengWei Capital and Cambium Capital.
– Rapid Silicon is headed by industry veteran Dr. Naveed Sherwani and has offices in San Jose and Shanghai, and plans to expand with additional offices in Europe and Asia.
– Rapid Silicon’s new generation of FPGAs targets a wide range of applications, allowing customers to introduce differentiated products in record time.

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Chengwei Capital?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 97
Average round size 31M
Rounds per year 3.88
Peak activity year 2017
Lead investments 23
Follow on index 0.29
Exits 6
Group Appearance index 0.87

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Biohem

$15M06 Mar 2024 Shanghai, Shanghai, China

Full-Life Technologies

Health Care
Manufacturing
Pharmaceutical
$47M03 Jan 2024 Shanghai, Shanghai, China

Perpetual Medicines

Biotechnology
$8M30 Nov 2023 -

Jushu Biotech

Biopharma
Biotechnology
Genetics
Medical
$15M17 Nov 2023 Changping, Beijing, China

Daochong Technology

Industrial Manufacturing
Information Technology
Wireless
07 Nov 2023 Yinzhou, Zhejiang, China

Huizhi International Tourism

Digital Marketing
Travel
Travel Agency
25 Sep 2023 Guangzhou, Guangdong, China

AroundDeal

Business Intelligence
Database
Information Technology
Lead Generation
Marketing
SaaS
Software
21 Jun 2023 Shanghai, Shanghai, China

Xunyuan Technology

Biopharma
Health Care
Medical
08 Feb 2023 Chongqing, Chongqing Shi, China

Jushu Biotech

Biopharma
Biotechnology
Genetics
Medical
$1M13 Jan 2023 Changping, Beijing, China
Crunchbase icon

Content report

The following text will be sent to our editors: